# Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid

> **NCT00603317** · PHASE4 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 13 (actual)

## Conditions studied

- Oral Anticoagulation
- Deep Venous Thrombosis
- Atrial Fibrillation
- Pulmonary Embolism

## Interventions

- **DRUG:** Firstly : Amoxicillin-Clavulanic acid and secondly : Placebo
- **DRUG:** Firstly : Placebo and secondly : Amoxicillin-Clavulanic acid

## Key facts

- **NCT ID:** NCT00603317
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2010-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603317, "Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00603317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
